PAR 2.50% 19.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-4342

  1. 200 Posts.
    lightbulb Created with Sketch. 42
    Now wouldn't it be great if they released both the go ahead from the FDA and a deal/funding transaction at the same time. This would bring one almighty gap up on open, It's a massive long shot but you just never know.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.